Causal Analysis of the TOPCAT Trial: Spironolactone for Preserved Cardiac Function Heart Failure

no code implementations • 23 Nov 2022 • Francesca E. D. Raimondi, Tadhg O'Keeffe, Hana Chockler, Andrew R. Lawrence, Tamara Stemberga, Andre Franca, Maksim Sipos, Javed Butler, Shlomo Ben-Haim

We describe the results of applying causal discovery methods on the data from a multi-site clinical trial, on the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT).

Causal Discovery